These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38711133)

  • 1. Rapid development and mass production of SARS-CoV-2 neutralizing chicken egg yolk antibodies with protective efficacy in hamsters.
    Zhao B; Peng H; Zhang Y; Zhang J; Kong D; Cao S; Li Y; Yang D; Sun C; Pu X; Zhao P; Xu Y; Zhao K; Xie L
    Biol Res; 2024 May; 57(1):24. PubMed ID: 38711133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An approach towards development of monoclonal IgY antibodies against SARS CoV-2 spike protein (S) using phage display method: A review.
    Somasundaram R; Choraria A; Antonysamy M
    Int Immunopharmacol; 2020 Aug; 85():106654. PubMed ID: 32512271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of SARS-CoV-2-Specific IgY Antibodies: Production, Reactivity, and Neutralizing Capability against Virus Variants.
    Schön J; Aebischer A; Halwe NJ; Ulrich L; Hoffmann D; Reiche S; Beer M; Grund C
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Egg yolk immunoglobulin (IgY) targeting SARS-CoV-2 S1 as potential virus entry blocker.
    Bao L; Zhang C; Lyu J; Yi P; Shen X; Tang B; Zhao H; Ren B; Kuang Y; Zhou L; Li Y
    J Appl Microbiol; 2022 Mar; 132(3):2421-2430. PubMed ID: 34706134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of Chicken IgY against SARS-COV-2 Spike Protein and Epitope Mapping.
    Lu Y; Wang Y; Zhang Z; Huang J; Yao M; Huang G; Ge Y; Zhang P; Huang H; Wang Y; Li H; Wang W
    J Immunol Res; 2020; 2020():9465398. PubMed ID: 33134398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction.
    Eka Saputri M; Aisyah Rahmalia Effendi S; Nadila R; Azzam Fajar S; Damajanti Soejoedono R; Handharyani E; Nadia Poetri O
    Int Immunopharmacol; 2022 Nov; 112():109280. PubMed ID: 36183680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chicken Egg Yolk Antibodies (IgYs) block the binding of multiple SARS-CoV-2 spike protein variants to human ACE2.
    Wei S; Duan S; Liu X; Wang H; Ding S; Chen Y; Xie J; Tian J; Yu N; Ge P; Zhang X; Chen X; Li Y; Meng Q
    Int Immunopharmacol; 2021 Jan; 90():107172. PubMed ID: 33191178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral Immunoglobulins of Chicken Egg Yolk for Potential Prevention of SARS-CoV-2 Infection.
    Ravlo E; Evensen L; Sanson G; Hildonen S; Ianevski A; Skjervold PO; Ji P; Wang W; Kaarbø M; Kaynova GD; Kainov DE; Bjørås M
    Viruses; 2022 Sep; 14(10):. PubMed ID: 36298676
    [No Abstract]   [Full Text] [Related]  

  • 9. Preclinical Assessment of IgY Antibodies Against Recombinant SARS-CoV-2 RBD Protein for Prophylaxis and Post-Infection Treatment of COVID-19.
    Agurto-Arteaga A; Poma-Acevedo A; Rios-Matos D; Choque-Guevara R; Montesinos-Millán R; Montalván Á; Isasi-Rivas G; Cauna-Orocollo Y; Cauti-Mendoza MG; Pérez-Martínez N; Gutierrez-Manchay K; Ramirez-Ortiz I; Núñez-Fernández D; Salguedo-Bohorquez MI; Quiñones-Garcia S; Fernández Díaz M; Guevara Sarmiento LA; Zimic M;
    Front Immunol; 2022; 13():881604. PubMed ID: 35664008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.
    Lu M; Zhang Y; Dravid P; Li A; Zeng C; Kc M; Trivedi S; Sharma H; Chaiwatpongsakorn S; Zani A; Kenney A; Cai C; Ye C; Liang X; Qiu J; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Peeples ME; Kapoor A; Li J
    J Virol; 2021 Sep; 95(20):e0059221. PubMed ID: 34379509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.
    van der Ley PA; Zariri A; van Riet E; Oosterhoff D; Kruiswijk CP
    Front Immunol; 2021; 12():781280. PubMed ID: 34987509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2.
    Tostanoski LH; Gralinski LE; Martinez DR; Schaefer A; Mahrokhian SH; Li Z; Nampanya F; Wan H; Yu J; Chang A; Liu J; McMahan K; Ventura JD; Dinnon KH; Leist SR; Baric RS; Barouch DH
    J Virol; 2021 Nov; 95(23):e0097421. PubMed ID: 34523968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity.
    Scaglione A; Opp S; Hurtado A; Lin Z; Pampeno C; Noval MG; Thannickal SA; Stapleford KA; Meruelo D
    Front Immunol; 2021; 12():719077. PubMed ID: 34394127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperimmunized Chickens Produce Neutralizing Antibodies against SARS-CoV-2.
    Aston EJ; Wallach MG; Narayanan A; Egaña-Labrin S; Gallardo RA
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replication.
    Artman C; Brumfield KD; Khanna S; Goepp J
    PLoS One; 2021; 16(5):e0252399. PubMed ID: 34048457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19.
    Frumkin LR; Lucas M; Scribner CL; Ortega-Heinly N; Rogers J; Yin G; Hallam TJ; Yam A; Bedard K; Begley R; Cohen CA; Badger CV; Abbasi SA; Dye JM; McMillan B; Wallach M; Bricker TL; Joshi A; Boon ACM; Pokhrel S; Kraemer BR; Lee L; Kargotich S; Agochiya M; John TS; Mochly-Rosen D
    Front Immunol; 2022; 13():899617. PubMed ID: 35720389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient Production of Human Norovirus-Specific IgY in Egg Yolks by Vaccination of Hens with a Recombinant Vesicular Stomatitis Virus Expressing VP1 Protein.
    Zhu Y; Ma Y; Lu M; Zhang Y; Li A; Liang X; Li J
    Viruses; 2019 May; 11(5):. PubMed ID: 31100802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
    Weisblum Y; Schmidt F; Zhang F; DaSilva J; Poston D; Lorenzi JC; Muecksch F; Rutkowska M; Hoffmann HH; Michailidis E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Luchsinger L; Hillyer CD; Caskey M; Robbiani DF; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
    Elife; 2020 Oct; 9():. PubMed ID: 33112236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection.
    Li T; Cai H; Yao H; Zhou B; Zhang N; van Vlissingen MF; Kuiken T; Han W; GeurtsvanKessel CH; Gong Y; Zhao Y; Shen Q; Qin W; Tian XX; Peng C; Lai Y; Wang Y; Hutter CAJ; Kuo SM; Bao J; Liu C; Wang Y; Richard AS; Raoul H; Lan J; Seeger MA; Cong Y; Rockx B; Wong G; Bi Y; Lavillette D; Li D
    Nat Commun; 2021 Jul; 12(1):4635. PubMed ID: 34330908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.